1. Home
  2. ADCT
  3. ADCT News

Latest ADC Therapeutics SA (ADCT) News on February 22, 2025

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADCT

PR Newswire

19 days ago

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
ADCT

PR Newswire

23 days ago

ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADCT

PR Newswire

2 months ago

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

Is ADC Therapeutics SA (NYSE:ADCT) Worth US$2.0 Based On Its Intrinsic Value?
ADCT

Simply Wall St.

2 months ago

Is ADC Therapeutics SA (NYSE:ADCT) Worth US$2.0 Based On Its Intrinsic Value?

ADCT

MT Newswires

2 months ago

Update: ADC Shares Rise After Company Completes Enrollment in Late-Stage Zynlonta Combination Trial

ADCT

MT Newswires

2 months ago

ADC Completes Enrollment in Late-Stage Zynlonta Combination Trial

ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma
ADCT

PR Newswire

2 months ago

ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma

ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma
ADCT

PR Newswire

2 months ago

ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma

ADC Therapeutics Announces The Lancet Haematology Publication of Data from Investigator-Initiated Trial Evaluating ZYNLONTA® in Combination with Rituximab to Treat Relapsed/Refractory Follicular Lymphoma
ADCT

PR Newswire

2 months ago

ADC Therapeutics Announces The Lancet Haematology Publication of Data from Investigator-Initiated Trial Evaluating ZYNLONTA® in Combination with Rituximab to Treat Relapsed/Refractory Follicular Lymphoma

ADCT

MT Newswires

3 months ago

Top Midday Gainers

ADC Therapeutics to Provide Initial Data Update on LOTIS-7 Clinical Trial
ADCT

PR Newswire

3 months ago

ADC Therapeutics to Provide Initial Data Update on LOTIS-7 Clinical Trial

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADCT

PR Newswire

3 months ago

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

BerGenBio ASA (FRA:7BG0) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Leadership ...
ADCT

GuruFocus.com

3 months ago

BerGenBio ASA (FRA:7BG0) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Leadership ...

ADC Therapeutics Third Quarter 2024 Earnings: EPS Misses Expectations
ADCT

Simply Wall St.

3 months ago

ADC Therapeutics Third Quarter 2024 Earnings: EPS Misses Expectations

ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why
ADCT

Benzinga

3 months ago

ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why

ADC Therapeutics SA (ADCT) Reports Q3 Loss, Lags Revenue Estimates
ADCT

Zacks

3 months ago

ADC Therapeutics SA (ADCT) Reports Q3 Loss, Lags Revenue Estimates

ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update
ADCT

PR Newswire

3 months ago

ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update

Amicus Therapeutics (FOLD) Q3 Earnings and Revenues Beat Estimates
ADCT

Zacks

4 months ago

Amicus Therapeutics (FOLD) Q3 Earnings and Revenues Beat Estimates

What To Expect From ADC Therapeutics SA (ADCT) Q3 2024 Earnings
ADCT

GuruFocus.com

4 months ago

What To Expect From ADC Therapeutics SA (ADCT) Q3 2024 Earnings

ADC Therapeutics Announces Investigator-Initiated Study Abstracts Accepted for Presentation at the 66th ASH Annual Meeting
ADCT

PR Newswire

4 months ago

ADC Therapeutics Announces Investigator-Initiated Study Abstracts Accepted for Presentation at the 66th ASH Annual Meeting

ADC Therapeutics to Present at November Investor Conferences
ADCT

PR Newswire

4 months ago

ADC Therapeutics to Present at November Investor Conferences

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADCT

PR Newswire

4 months ago

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?
ADCT

Zacks

4 months ago

Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?

ADC Therapeutics to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024
ADCT

PR Newswire

4 months ago

ADC Therapeutics to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024

Institutional investors own a significant stake of 32% in ADC Therapeutics SA (NYSE:ADCT)
ADCT

Simply Wall St.

4 months ago

Institutional investors own a significant stake of 32% in ADC Therapeutics SA (NYSE:ADCT)

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADCT

GlobeNewswire

5 months ago

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADCT

GlobeNewswire

6 months ago

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

ADC Therapeutics to Present at Upcoming Investor Conferences
ADCT

GlobeNewswire

6 months ago

ADC Therapeutics to Present at Upcoming Investor Conferences

ADC Therapeutics Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
ADCT

Simply Wall St.

6 months ago

ADC Therapeutics Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates
ADCT

Zacks

7 months ago

ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates

ADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
ADCT

GlobeNewswire

7 months ago

ADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

Vertex Pharmaceuticals (VRTX) Reports Q2 Loss, Misses Revenue Estimates
ADCT

Zacks

7 months ago

Vertex Pharmaceuticals (VRTX) Reports Q2 Loss, Misses Revenue Estimates

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADCT

GlobeNewswire

7 months ago

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

ADC Therapeutics to Host Second Quarter 2024 Financial Results Conference Call on August 6, 2024
ADCT

GlobeNewswire

7 months ago

ADC Therapeutics to Host Second Quarter 2024 Financial Results Conference Call on August 6, 2024

Myricx Bio Announces ÂŁ90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development
ADCT

GlobeNewswire

7 months ago

Myricx Bio Announces ÂŁ90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADCT

GlobeNewswire

8 months ago

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

ADC Therapeutics SA (NYSE:ADCT) Shares Could Be 50% Below Their Intrinsic Value Estimate
ADCT

Simply Wall St.

8 months ago

ADC Therapeutics SA (NYSE:ADCT) Shares Could Be 50% Below Their Intrinsic Value Estimate

ADCT

MT Newswires

8 months ago

ADC Therapeutics to Join Russell 3000 Index

ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
ADCT

GlobeNewswire

8 months ago

ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADCT

GlobeNewswire

9 months ago

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

ADCT

MT Newswires

9 months ago

Cantor Fitzgerald Initiates ADC Therapeutics at Overweight Rating

ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference
ADCT

GlobeNewswire

9 months ago

ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference

ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
ADCT

GlobeNewswire

9 months ago

ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

ADC Therapeutics First Quarter 2024 Earnings: In Line With Expectations
ADCT

Simply Wall St.

9 months ago

ADC Therapeutics First Quarter 2024 Earnings: In Line With Expectations

Insider Sale: CEO Ameet Mallik Sells 29,731 Shares of ADC Therapeutics SA (ADCT)
ADCT

GuruFocus.com

9 months ago

Insider Sale: CEO Ameet Mallik Sells 29,731 Shares of ADC Therapeutics SA (ADCT)

ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
ADCT

GlobeNewswire

9 months ago

ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference

ADC Therapeutics SA (NYSE:ADCT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
ADCT

Simply Wall St.

9 months ago

ADC Therapeutics SA (NYSE:ADCT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

ADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript
ADCT

Insider Monkey

10 months ago

ADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript

ADCT

MT Newswires

10 months ago

HC Wainwright Adjusts Price Target on ADC Therapeutics to $8 From $9, Maintains Buy Rating

ADCT

MT Newswires

10 months ago

ADC Therapeutics Launches $105 Million Offering; Shares Up 2% Pre-Bell

ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants
ADCT

GlobeNewswire

10 months ago

ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants

ADC Therapeutics SA (ADCT) Reports Q1 Loss, Misses Revenue Estimates
ADCT

Zacks

10 months ago

ADC Therapeutics SA (ADCT) Reports Q1 Loss, Misses Revenue Estimates

ADCT

MT Newswires

10 months ago

ADC Therapeutics SA's Cancer Drug Candidate Shows High Response Rate in Phase 2 Trial

ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
ADCT

GlobeNewswire

10 months ago

ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone Lymphoma
ADCT

GlobeNewswire

10 months ago

ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone Lymphoma

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADCT

GlobeNewswire

10 months ago

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024
ADCT

GlobeNewswire

10 months ago

ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024

ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
ADCT

GlobeNewswire

a year ago

ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024
ADCT

GlobeNewswire

a year ago

ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADCT

GlobeNewswire

a year ago

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

US$10.00 - That's What Analysts Think ADC Therapeutics SA (NYSE:ADCT) Is Worth After These Results
ADCT

Simply Wall St.

a year ago

US$10.00 - That's What Analysts Think ADC Therapeutics SA (NYSE:ADCT) Is Worth After These Results

ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript
ADCT

Insider Monkey

a year ago

ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript

ADCT

Thomson Reuters StreetEvents

a year ago

Q4 2023 ADC Therapeutics SA Earnings Call

ADCT

GuruFocus.com

a year ago

ADC Therapeutics SA (ADCT) Reports Mixed 2023 Financial Results Amid Strategic Reset

ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates
ADCT

Zacks

a year ago

ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates

ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
ADCT

GlobeNewswire

a year ago

ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates

Adobe (ADBE) to Report Q1 Earnings: What's in the Offing?
ADCT

Zacks

a year ago

Adobe (ADBE) to Report Q1 Earnings: What's in the Offing?

Zymeworks Inc. (ZYME) Reports Q4 Loss, Misses Revenue Estimates
ADCT

Zacks

a year ago

Zymeworks Inc. (ZYME) Reports Q4 Loss, Misses Revenue Estimates

ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit
ADCT

GlobeNewswire

a year ago

ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit

ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024
ADCT

GlobeNewswire

a year ago

ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024

ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting
ADCT

GlobeNewswire

a year ago

ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting

ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
ADCT

GlobeNewswire

a year ago

ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

Earnings Preview: Cytek Biosciences, Inc. (CTKB) Q4 Earnings Expected to Decline
ADCT

Zacks

a year ago

Earnings Preview: Cytek Biosciences, Inc. (CTKB) Q4 Earnings Expected to Decline

Earnings Preview: ADC Therapeutics SA (ADCT) Q4 Earnings Expected to Decline
ADCT

Zacks

a year ago

Earnings Preview: ADC Therapeutics SA (ADCT) Q4 Earnings Expected to Decline

15 Top Performing European Stocks So Far in 2024
ADCT

Insider Monkey

a year ago

15 Top Performing European Stocks So Far in 2024

The 3 Biotech Stocks That Could Make Your February Unforgettable
ADCT

InvestorPlace

a year ago

The 3 Biotech Stocks That Could Make Your February Unforgettable

Biogen Inc. (BIIB) Lags Q4 Earnings and Revenue Estimates
ADCT

Zacks

a year ago

Biogen Inc. (BIIB) Lags Q4 Earnings and Revenue Estimates

The 3 Most Undervalued Biotech Stocks to Buy in February 2024
ADCT

InvestorPlace

a year ago

The 3 Most Undervalued Biotech Stocks to Buy in February 2024

Hawaiian Holdings Inc (HA) Faces Headwinds: A Detailed Look at Q4 and Full Year 2023 Results
ADCT

GuruFocus.com

a year ago

Hawaiian Holdings Inc (HA) Faces Headwinds: A Detailed Look at Q4 and Full Year 2023 Results

Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year?
ADCT

Zacks

a year ago

Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year?

Independent Bank Corporation Reports 2023 Fourth Quarter Results
ADCT

GlobeNewswire

a year ago

Independent Bank Corporation Reports 2023 Fourth Quarter Results

ADCT

Associated Press Finance

a year ago

MarineMax: Fiscal Q1 Earnings Snapshot

Recent Price Trend in Alico (ALCO) is Your Friend, Here's Why
ADCT

Zacks

a year ago

Recent Price Trend in Alico (ALCO) is Your Friend, Here's Why

Verastem (VSTM) Up 8% on Fast Track Tag for NSCLC Combo Therapy
ADCT

Zacks

a year ago

Verastem (VSTM) Up 8% on Fast Track Tag for NSCLC Combo Therapy

ADC Therapeutics (ADCT) Rises 43% in a Month: Here's Why
ADCT

Zacks

a year ago

ADC Therapeutics (ADCT) Rises 43% in a Month: Here's Why

Is ADC Therapeutics (ADCT) Outperforming Other Medical Stocks This Year?
ADCT

Zacks

a year ago

Is ADC Therapeutics (ADCT) Outperforming Other Medical Stocks This Year?

Calculating The Fair Value Of The Aaron's Company, Inc. (NYSE:AAN)
ADCT

Simply Wall St.

a year ago

Calculating The Fair Value Of The Aaron's Company, Inc. (NYSE:AAN)

ADCT

Business Wire

a year ago

Evans Bancorp Announces Fourth Quarter and Full Year 2023 Conference Call and Webcast

Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases
ADCT

GlobeNewswire

a year ago

Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases

Backblaze Launches Enterprise Control to Support Advanced Administration and Data Protection Needs
ADCT

GlobeNewswire

a year ago

Backblaze Launches Enterprise Control to Support Advanced Administration and Data Protection Needs

Akoya Biosciences, Inc.'s (NASDAQ:AKYA) market cap touched US$254m last week, benefiting both private equity firms who own 48% as well as institutions
ADCT

Simply Wall St.

a year ago

Akoya Biosciences, Inc.'s (NASDAQ:AKYA) market cap touched US$254m last week, benefiting both private equity firms who own 48% as well as institutions

A Look Back at Automotive and Marine Retail Stocks' Q3 Earnings: MarineMax (NYSE:HZO) Vs The Rest Of The Pack
ADCT

StockStory

a year ago

A Look Back at Automotive and Marine Retail Stocks' Q3 Earnings: MarineMax (NYSE:HZO) Vs The Rest Of The Pack

GLOBAL SURVEY REVEALS AFFLUENT HOME SEEKERS EXPANDING REACHES AND SUSTAINABILITY IS TOP OF MIND
ADCT

PR Newswire

a year ago

GLOBAL SURVEY REVEALS AFFLUENT HOME SEEKERS EXPANDING REACHES AND SUSTAINABILITY IS TOP OF MIND

Are Medical Stocks Lagging Cigna Group (CI) This Year?
ADCT

Zacks

a year ago

Are Medical Stocks Lagging Cigna Group (CI) This Year?

Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board
ADCT

GlobeNewswire

a year ago

Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board

Best Momentum Stocks to Buy for January 8th
ADCT

Zacks

a year ago

Best Momentum Stocks to Buy for January 8th

Why Fast-paced Mover Jakks (JAKK) Is a Great Choice for Value Investors
ADCT

Zacks

a year ago

Why Fast-paced Mover Jakks (JAKK) Is a Great Choice for Value Investors

ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards
ADCT

GlobeNewswire

a year ago

ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards

ADC Therapeutics Provides Business Updates
ADCT

GlobeNewswire

a year ago

ADC Therapeutics Provides Business Updates

XOMA Announces Stock Repurchase Program of up to $50 Million
ADCT

GlobeNewswire

a year ago

XOMA Announces Stock Repurchase Program of up to $50 Million

Share on Social Networks: